Published in Med J Aust on October 16, 2017
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Melioidosis. N Engl J Med (2012) 6.94
Development and evaluation of a real-time PCR assay targeting the type III secretion system of Burkholderia pseudomallei. J Clin Microbiol (2006) 2.94
Phylogeographic reconstruction of a bacterial species with high levels of lateral gene transfer. BMC Biol (2009) 2.94
Nonrandom distribution of Burkholderia pseudomallei clones in relation to geographical location and virulence. J Clin Microbiol (2006) 2.34
Acute rheumatic fever: a chink in the chain that links the heart to the throat? Lancet Infect Dis (2004) 2.33
Management of accidental laboratory exposure to Burkholderia pseudomallei and B. mallei. Emerg Infect Dis (2008) 2.24
Clinical toxinology--where are we now? J Toxicol Clin Toxicol (2003) 2.23
Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis (2009) 2.20
Scabies: a ubiquitous neglected skin disease. Lancet Infect Dis (2006) 2.18
Low rates of streptococcal pharyngitis and high rates of pyoderma in Australian aboriginal communities where acute rheumatic fever is hyperendemic. Clin Infect Dis (2006) 1.94
Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation. J Clin Microbiol (2004) 1.88
Indirect hemagglutination assay in patients with melioidosis in northern Australia. Am J Trop Med Hyg (2006) 1.82
A horizontal gene transfer event defines two distinct groups within Burkholderia pseudomallei that have dissimilar geographic distributions. J Bacteriol (2007) 1.82
Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics (2008) 1.82
Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev (2007) 1.81
Murray Valley encephalitis: a review of clinical features, diagnosis and treatment. Med J Aust (2012) 1.77
Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii. Clin Infect Dis (2013) 1.76
Landscape changes influence the occurrence of the melioidosis bacterium Burkholderia pseudomallei in soil in northern Australia. PLoS Negl Trop Dis (2009) 1.74
Systematic review and consensus guidelines for environmental sampling of Burkholderia pseudomallei. PLoS Negl Trop Dis (2013) 1.72
Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. MBio (2013) 1.66
A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis (2007) 1.64
Sensitive and specific molecular detection of Burkholderia pseudomallei, the causative agent of melioidosis, in the soil of tropical northern Australia. Appl Environ Microbiol (2007) 1.62
Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis (2002) 1.60
Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis (2011) 1.57
Genetic diversity of Burkholderia pseudomallei isolates in Australia. J Clin Microbiol (2007) 1.56
Dengue and climate change in Australia: predictions for the future should incorporate knowledge from the past. Med J Aust (2009) 1.55
Irukandji syndrome case series from Australia's Tropical Northern Territory. Ann Emerg Med (2009) 1.54
Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping. BMC Microbiol (2007) 1.54
Vibrio vulnificus and V. parahaemolyticus necrotising fasciitis in fishermen visiting an estuarine tropical northern Australian location. J Infect (2006) 1.51
Disease burden and health-care clinic attendances for young children in remote aboriginal communities of northern Australia. Bull World Health Organ (2008) 1.51
A very early-branching Staphylococcus aureus lineage lacking the carotenoid pigment staphyloxanthin. Genome Biol Evol (2011) 1.51
Clonality and recombination in genetically differentiated subgroups of Cryptococcus gattii. Eukaryot Cell (2005) 1.48
Accuracy of Burkholderia pseudomallei identification using the API 20NE system and a latex agglutination test. J Clin Microbiol (2007) 1.48
Workshop on treatment of and postexposure prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerg Infect Dis (2012) 1.48
Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother (2004) 1.48
Cutaneous melioidosis in the tropical top end of Australia: a prospective study and review of the literature. Clin Infect Dis (2008) 1.48
Adjunctive granulocyte colony-stimulating factor for treatment of septic shock due to melioidosis. Clin Infect Dis (2003) 1.44
Extreme weather events and environmental contamination are associated with case-clusters of melioidosis in the Northern Territory of Australia. Int J Epidemiol (2005) 1.43
Use of a single-nucleotide polymorphism genotyping system to demonstrate the unique epidemiology of methicillin-resistant Staphylococcus aureus in remote aboriginal communities. J Clin Microbiol (2006) 1.43
Is Streptococcus pyogenes resistant or susceptible to trimethoprim-sulfamethoxazole? J Clin Microbiol (2012) 1.42
Pneumonia risk stratification in tropical Australia: does the SMART-COP score apply? Med J Aust (2010) 1.41
VNTR analysis of selected outbreaks of Burkholderia pseudomallei in Australia. Infect Genet Evol (2006) 1.40
Community-acquired bacteremic Acinetobacter pneumonia in tropical Australia is caused by diverse strains of Acinetobacter baumannii, with carriage in the throat in at-risk groups. J Clin Microbiol (2002) 1.39
Lipopolysaccharide heterogeneity among Burkholderia pseudomallei from different geographic and clinical origins. Am J Trop Med Hyg (2006) 1.39
Melioidosis in northern Australia, 2001-02. Commun Dis Intell Q Rep (2003) 1.37
A regional initiative to reduce skin infections amongst aboriginal children living in remote communities of the Northern Territory, Australia. PLoS Negl Trop Dis (2009) 1.35
Cystic Fibrosis and Burkholderia pseudomallei Infection: An Emerging Problem? Clin Infect Dis (2002) 1.35
Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis (2010) 1.29
Scabies: new future for a neglected disease. Adv Parasitol (2004) 1.29
Melioidosis at Royal Darwin Hospital in the big 2009-2010 wet season: comparison with the preceding 20 years. Med J Aust (2012) 1.29
Burkholderia pseudomallei genome plasticity associated with genomic island variation. BMC Genomics (2008) 1.28
Group A streptococci from a remote community have novel multilocus genotypes but share emm types and housekeeping alleles with isolates from worldwide sources. J Infect Dis (2004) 1.27
Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust (2006) 1.27
Epidemiology of Streptococcus dysgalactiae subsp. equisimilis in tropical communities, Northern Australia. Emerg Infect Dis (2007) 1.26
Epidemiology of community-acquired and nosocomial bloodstream infections in tropical Australia: a 12-month prospective study. Trop Med Int Health (2004) 1.24
Clinical definitions of melioidosis. Am J Trop Med Hyg (2013) 1.24
Inter-species genetic movement may blur the epidemiology of streptococcal diseases in endemic regions. Microbes Infect (2005) 1.22
Clinical evaluation of a type III secretion system real-time PCR assay for diagnosing melioidosis. J Clin Microbiol (2006) 1.20
Prevalence and sequence diversity of a factor required for actin-based motility in natural populations of Burkholderia species. J Clin Microbiol (2008) 1.18
Contamination of hand wash detergent linked to occupationally acquired melioidosis. Am J Trop Med Hyg (2004) 1.16
Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in Indigenous populations. Clin Infect Dis (2008) 1.16
Phylogenetically distinct Staphylococcus aureus lineage prevalent among indigenous communities in northern Australia. J Clin Microbiol (2009) 1.14
Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus. Infect Immun (2005) 1.14
Scabies: a suitable case for a global control initiative. Curr Opin Infect Dis (2013) 1.13
Diversity of 16S-23S rDNA internal transcribed spacer (ITS) reveals phylogenetic relationships in Burkholderia pseudomallei and its near-neighbors. PLoS One (2011) 1.13
Burkholderia pseudomallei in unchlorinated domestic bore water, Tropical Northern Australia. Emerg Infect Dis (2011) 1.13
Recovery of a Burkholderia thailandensis-like isolate from an Australian water source. BMC Microbiol (2008) 1.12
BurkDiff: a real-time PCR allelic discrimination assay for Burkholderia pseudomallei and B. mallei. PLoS One (2010) 1.11
Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol (2004) 1.11
Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol (2008) 1.10
Mechanisms for a novel immune evasion strategy in the scabies mite sarcoptes scabiei: a multigene family of inactivated serine proteases. J Invest Dermatol (2003) 1.10
Plasminogen binding by group A streptococcal isolates from a region of hyperendemicity for streptococcal skin infection and a high incidence of invasive infection. Infect Immun (2004) 1.09
Recurrent melioidosis in the Darwin Prospective Melioidosis Study: improving therapies mean that relapse cases are now rare. J Clin Microbiol (2013) 1.08
Expression of resistance-nodulation-cell-division efflux pumps in commonly used Burkholderia pseudomallei strains and clinical isolates from northern Australia. Trans R Soc Trop Med Hyg (2008) 1.08
Clonality and α-a recombination in the Australian Cryptococcus gattii VGII population--an emerging outbreak in Australia. PLoS One (2011) 1.08
Out of the ground: aerial and exotic habitats of the melioidosis bacterium Burkholderia pseudomallei in grasses in Australia. Environ Microbiol (2011) 1.08
Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia. PLoS One (2012) 1.07
Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am J Trop Med Hyg (2008) 1.07
Short report: application of a polymerase chain reaction to detect Burkholderia pseudomallei in clinical specimens from patients with suspected melioidosis. Am J Trop Med Hyg (2005) 1.07
Acute post-streptococcal glomerulonephritis in the Northern Territory of Australia: a review of 16 years data and comparison with the literature. Am J Trop Med Hyg (2011) 1.05
Prostatic abscess due to Burkholderia pseudomallei: 81 cases from a 19-year prospective melioidosis study. J Urol (2009) 1.05
Fibronectin-binding protein gene recombination and horizontal transfer between group A and G streptococci. J Clin Microbiol (2004) 1.03
Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am (2009) 1.03
Generation and characterization of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg (2003) 1.03
Molecular investigations of a locally acquired case of melioidosis in Southern AZ, USA. PLoS Negl Trop Dis (2011) 1.03
Intersexual variations in Northern (Missulena pruinosa) and Eastern (M. bradleyi) mouse spider venom. Toxicon (2008) 1.02
Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis. Med J Aust (2008) 1.02
Factors supporting sustainability of a community-based scabies control program. Australas J Dermatol (2002) 1.01
B-cell antigen D8/17 is a marker of rheumatic fever susceptibility in Aboriginal Australians and can be tested in remote settings. Med J Aust (2006) 1.01
Molecular characterization of clinical Burkholderia pseudomallei isolates from India. Am J Trop Med Hyg (2011) 1.01
Practical challenges of conducting research into rheumatic fever in remote Aboriginal communities. Med J Aust (2006) 1.00
Acaricidal activity of Melaleuca alternifolia (tea tree) oil: in vitro sensitivity of sarcoptes scabiei var hominis to terpinen-4-ol. Arch Dermatol (2004) 1.00
Recovering streptococci from the throat, a practical alternative to direct plating in remote tropical communities. J Clin Microbiol (2006) 1.00
The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide. PLoS Negl Trop Dis (2012) 0.99
Diagnosis and treatment of mycotic aneurysm due to Burkholderia pseudomallei. Clin Infect Dis (2005) 0.98
Burkholderia pseudomallei strain type, based on pulsed-field gel electrophoresis, does not determine disease presentation in melioidosis. Microbes Infect (2004) 0.97
Epidemiological tracking and population assignment of the non-clonal bacterium, Burkholderia pseudomallei. PLoS Negl Trop Dis (2011) 0.97
Use of a variable amplicon typing scheme reveals considerable variation in the accessory genomes of isolates of Burkholderia pseudomallei. J Clin Microbiol (2006) 0.96
Melioidosis in Birds and Burkholderia pseudomallei Dispersal, Australia. Emerg Infect Dis (2011) 0.96